Latest Press Release on flu vaccine

Military Study Shows Prevention of Novel A/H1N1 Virus Infection is Vaccine-Type and Age-Dependent
WASHINGTON, Nov. 19 /PRNewswire/ -- Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza ...

---

National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers
BOSTON, Nov. 18 /PRNewswire/ -- The National Patient Safety Foundation (NPSF) today issued the following position statement supporting mandatory influenza vaccination of health care workers: The National Patient Safety Foundation recognizes vaccine-preventab...

---

Macomb County Health Department Schedules Communitywide H1N1 Flu Vaccine Clinic Nov. 24
MT. CLEMENS, Mich., Nov. 18 /PRNewswire/ -- A communitywide H1N1 vaccine clinic has been scheduled for next Tuesday, Nov. 24, the Macomb County Health Department announced today. It is being offered at no charge. The clinic will be held from noon to 7 p.m. at Freedom Hill...

---

BusinessWeek Names Genocea Biosciences One of the World’s Most Intriguing Startups
CAMBRIDGE, Mass. - Genocea Biosciences, a leading vaccine discovery and development company

---

Hard to Treat Diseases' (HTDS) MMR Vaccine Passed the Chinese SFDA's 'First Drug Evaluation'
SHENZHEN, China, Nov. 16 - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China subsidiary Mellow Hope announce that its MMR vaccine (Measles, Mumps and Ru...

---

NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico
ROCKVILLE, Md., Nov. 16 -- Novavax, Inc. (Nasdaq: NVAX) announced today that enrollment has been completed in the first stage of a two-stage clinical study of its novel 2009 H1N1 virus-like-particle (VLP) pandemic influenza unadjuvanted vaccine in the country of M...

---

Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available
HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewswire/ -- The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine. A total of 18 clinics are being held statewide on Nov. 20-22. Friday's clinic...

---

AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing
VIENNA, Austria, November 19 /PRNewswire/ -- AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in...

---

Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
BEIJING, Nov. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it was selected by the Shanghai Government to supply its inactivated hepatitis A vaccine, Healive, to the public market of Shanghai. Out of the f...

---

Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several

---

Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model. Dr

---

Department of Health Updates H1N1 Vaccine Distribution Effort, Reminds At-Risk Residents of Upcoming Vaccination Clinics
HARRISBURG, Pa., Nov. 16 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,686,100 doses of H1N1 vaccine to Pennsylvania to date, the Department of Health said today. The vaccine has been distributed to 1,31...

---

GAVI’s Impact on Vaccine Market is Bringing Down Prices
HANOI, Vietnam - Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably, enabling GAVI’s partners to vaccinate millions of more children in the developing world.

---